Does Crestor Cause Muscle Pain?
Yes, Crestor (rosuvastatin), a statin used to lower cholesterol, causes muscle pain in some patients. This side effect, known as myalgia, affects 2-10% of users in clinical trials and is a well-documented risk listed in its FDA prescribing information.[1] Pain can range from mild soreness to severe myopathy or, rarely, rhabdomyolysis (muscle breakdown that damages kidneys).
How Common Is Muscle Pain on Crestor?
Muscle-related symptoms occur in about 5-12% of patients on rosuvastatin, higher at doses of 40 mg daily. Post-marketing reports show higher rates in real-world use, especially among older adults, women, or those with low body weight.[1][2] A 2013 meta-analysis of 135 trials found statins like Crestor increase myalgia risk by 7-29% over placebo.[3]
Why Does Crestor Cause Muscle Pain?
Statins block HMG-CoA reductase, reducing cholesterol but also depleting coenzyme Q10 and disrupting muscle cell energy. Genetic factors like SLCO1B1 variants raise risk by impairing statin clearance from the liver, concentrating it in muscles.[4] Drug interactions (e.g., with gemfibrozil or cyclosporine) amplify this by 5-10 fold.[1]
How Does Crestor Compare to Other Statins for Muscle Pain?
Crestor has higher myopathy risk than less potent statins like pravastatin (odds ratio 1.6-3.0 times greater), but similar to atorvastatin (Lipitor).[3][5] Lipophilic statins (Crestor, Lipitor) may cause more pain than hydrophilic ones (pravastatin, rosuvastatin is intermediate).[2] Switching statins resolves symptoms in 30-70% of cases.[4]
| Statin | Myalgia Incidence (High Dose) | Relative Risk vs Placebo |
|--------|-------------------------------|--------------------------|
| Crestor (40 mg) | 12.7% | 1.5-3.0 |
| Lipitor (80 mg) | 14.9% | 1.4-2.5 |
| Pravastatin (40 mg) | 2.8% | 1.1-1.5 |
| Zocor (80 mg) | 5.0% | 1.2-2.0 |
Data from FDA labels and meta-analyses.[1][3]
What Should You Do If You Get Muscle Pain on Crestor?
Stop the drug and contact your doctor immediately—unexplained pain with weakness or dark urine signals rhabdomyolysis (risk 0.01-0.44 per 1,000 patient-years).[1] Doctors may test CK levels, lower dose, switch statins, or add CoQ10 (evidence mixed).[4] Risk calculators like the Statin-Associated Muscle Symptom Clinical Index guide management.[2]
Who Is at Higher Risk?
- Age over 65
- Hypothyroidism or kidney/liver disease
- Asian descent (2x higher exposure)
- Multiple meds or heavy alcohol use
- Exercise or grapefruit juice (increases levels 1.3-fold)[1][4]
When Does the Patent Expire and Are There Cheaper Alternatives?
Crestor's key patents expired in 2016 in the US, enabling generics (rosuvastatin calcium) priced at $0.10-$0.50 per pill vs. $5+ for brand.[6] No active patents block generics per DrugPatentWatch.[6] Biosimilars aren't applicable as it's synthetic.
Sources
[1]: FDA Crestor Label
[2]: Mayo Clinic Statin Side Effects
[3]: Lancet Meta-Analysis (2013)
[4]: NEJM Genetics Review (2013)
[5]: JAMA Comparison (2019)
[6]: DrugPatentWatch - Crestor